2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
2046
Neoplasms
1460
Carcinoma, Non-Small-Cell Lung
1365
Prostatic Neoplasms
1106
Multiple Myeloma
873
Leukemia, Myeloid, Acute
773
Colorectal Neoplasms
714
Neoplasm Metastasis
706
Lung Neoplasms
697
Melanoma
688
Lymphoma
667
Leukemia
596
Lymphoma, Non-Hodgkin
593
Ovarian Neoplasms
536
Leukemia, Lymphocytic, Chronic, B-Cell
535
Pancreatic Neoplasms
500
Precursor Cell Lymphoblastic Leukemia-Lymphoma
485
Recurrence
474
Myelodysplastic Syndromes
425
Lymphoma, Follicular
419
Carcinoma, Renal Cell
412
Head and Neck Neoplasms
408
Glioblastoma
380
Lymphoma, Large B-Cell, Diffuse
379
Brain Neoplasms
376
Hodgkin Disease
354
Carcinoma, Hepatocellular
333
Squamous Cell Carcinoma of Head and Neck
326
Lymphoma, Mantle-Cell
307
Sarcoma
286
Interventions
regorafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Physician Education
×
Clear all
NCT02287025
2017-10-19
SMART
Bayer
Phase 4
Terminated
23 enrolled
6 charts